Review
Cetuximab antibody and fragment-engineered nanoplatforms in targeted cancer therapy and diagnosis
M. Jalalvand, H. E. Lashgarian, Fariba Esmaeili et al.
· 0 citations
We have 2 of 4 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
An overview of recent progress in multi-omics approaches is provided and significant miRNA-, lncRNA-, and exosome-related biomarkers associated with the initiation, progression, and therapeutic response of breast cancer are emphasized.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.